SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Omeros
An SI Board Since March 2010
Posts SubjectMarks Bans Symbol
464 28 0 OMER
Emcee:  Bradpalm1 Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
189I'm thinking that someplace soon we should be getting a buying opportunity? Steve Lokness-11/21/2013
188 Omeros Announces FDA Acceptance of Omidria™ as Proprietary Name for OMS302 -- EHoward Williams-11/20/2013
187 Omeros Reports Phase 3 OMS302 Clinical Data Presented at the Annual American AcHoward Williams-11/19/2013
186Omeros to Present Data from OMS302 Phase 3 Clinical Program at the American AcadHoward Williams-11/12/2013
185 Omeros Corporation Reports Third Quarter 2013 Financial Results -- Obtains AddiHoward Williams-11/7/2013
184Omeros Announces Positive OMS721 Data in Model of Age-Related Macular DegeneratiHoward Williams-11/5/2013
183OMER 8-K out ....... receipt of the $12.5 million from the insurance company ***Howard Williams-10/24/2013
182Omeros Corporation Files Universal Shelf Registration Statement to Replace ExpirHoward Williams-10/17/2013
181In the press release, I got a kick out of this: <An average of 63-percent ocBiotech Jim-10/17/2013
180Omeros Reports Additional Positive Clinical Data for its Drug Candidate to TreatHoward Williams-10/17/2013
179Yep Khris, I'm here too. Welcome to the board. Not many posters here but IHoward Williams-10/16/2013
178Howard you are here too? I moved my TSRX into this one. Still have higher hopesKhris Smith-10/15/2013
177FDA Agrees with Omeros' Pediatric Study Plan for OMS302 -- Completion of PHoward Williams-10/15/2013
176Omeros Hires Michael K. Inouye to Lead Commercial Operations SEATTLE, Oct. 8, Howard Williams-10/8/2013
175Motley Fool article .... ******************************* What's Moving TheseHoward Williams-10/4/2013
174"Omeros has identified small molecules that interact with two non-orphan ClBiotech Jim-10/3/2013
173>>seems as if they are lining up the stars!<< Exactly, Steve.Howard Williams-10/3/2013
172<<<< he elected to receive no portion of the settlement funds and tSteve Lokness-10/3/2013
171 Omeros Settles Insurance Litigation -- Omeros to Receive $12.5 Million -- SEATTHoward Williams-10/3/2013
170 Omeros Unlocks Six Additional Class A Orphan GPCRs and Identifies Small MoleculHoward Williams-10/3/2013
169From SeekingAlpha .... *********************** Upbeat comments from Wedbush on eHoward Williams-10/2/2013
168US & European Regulators Accept For Review Omeros'OMS302 Marketing AppliHoward Williams-10/2/2013
167 FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's DHoward Williams-9/30/2013
166Another SeekingAlpha mention ....... (made when OMER was up more earlier today) Howard Williams-9/25/2013
165#1 for the week ........ 3 Humongous Health-Care Stocks This Week By Keith SpeHoward Williams-9/21/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News